Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2005
07/14/2005US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases
07/14/2005US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
07/14/2005US20050154022 Selective antagonists for melanin concentrating hormone-1 (MCH1) receptors; antidepressants, anxiolytic agents; bipolar, eating, psychological, urogenital, and obsessive-compulsive disorders; phobias, post-traumatic stress disorder
07/14/2005US20050154019 Substituted cyclic amine metalloprotease inhibitors
07/14/2005US20050154008 Aryl fused substituted 4-oxy-pyridines
07/14/2005US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition
07/14/2005US20050153998 Tetrahydroisoquinoline or isochroman compounds
07/14/2005US20050153997 Fredericamycin derivatives
07/14/2005US20050153987 Compounds
07/14/2005US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one
07/14/2005US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis
07/14/2005US20050153980 Substituted indoles
07/14/2005US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof
07/14/2005US20050153975 Y823D, N822K or D816H mutations in the c-Kit tyrosine kinase; antitumour agent; alternative to radiation or chemotherapy; reduce consequent infertility; good tolerability of compound mesylate treatment; no drug-related liver, renal or cardiac toxicity
07/14/2005US20050153974 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
07/14/2005US20050153972 Triazole compounds
07/14/2005US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
07/14/2005US20050153965 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/14/2005US20050153964 Novel compounds
07/14/2005US20050153960 Substituted arylamine derivatives and methods of use
07/14/2005US20050153959 Heterocyclic anti-migraine agents
07/14/2005US20050153958 Substituted aryl ketones
07/14/2005US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof
07/14/2005US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease
07/14/2005US20050153371 Conjugated small molecules
07/14/2005US20050151467 Electrochromic salts, solutions, and devices
07/14/2005DE10358004A1 Ketolactam-Verbindungen und ihre Verwendung -Keto lactam compounds and their use
07/14/2005CA2801848A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity
07/14/2005CA2551604A1 Amidopyrazole derivative
07/14/2005CA2551602A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity
07/14/2005CA2551227A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
07/14/2005CA2550894A1 Plant growth regulation
07/14/2005CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005CA2548309A1 Aryl sulfonamide compounds and uses related thereto
07/13/2005EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore
07/13/2005EP1553096A1 Pyrazole compounds
07/13/2005EP1553092A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
07/13/2005EP1553089A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
07/13/2005EP1553085A1 Cyclic amine derivatives and their use as drugs
07/13/2005EP1553084A1 Piperidine derivative, process for producing the same, and use
07/13/2005EP1551834A1 Substituted quinazolinone compounds
07/13/2005EP1551830A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators
07/13/2005EP1551829A2 Novel compounds with antibacterial activity
07/13/2005EP1551827A1 Piperidine derivatives as ccr5 inhibitors
07/13/2005EP1551826A1 Hydantoine derivatives and their use as tace inhibitors
07/13/2005EP1551825A1 Novel direct black dyes with three heteroaromatic rings
07/13/2005EP1551824A1 Protein tyrosine kinase inhibitors
07/13/2005EP1551823A1 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
07/13/2005EP1551812A2 Mitotic kinesin inhibitors
07/13/2005EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
07/13/2005EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
07/13/2005EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders
07/13/2005EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
07/13/2005EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists
07/13/2005EP1551795A1 Inhibitors of histone deacetylase
07/13/2005EP1551408A1 4-(4-methylpiperazin-1-ylmethyl)-n- 4-pyridin-3-yl)pyrimidin -2-ylamino)phenyl -benzamide for treating anaplastic thyroid cancer
07/13/2005EP1551404A2 Method of inhibiting angiogenesis
07/13/2005EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity
07/13/2005EP1178969B1 Gastrin and cholecystokinin receptor ligands
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
07/13/2005EP0949249B1 Process for producing imidazole derivatives
07/13/2005CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors
07/13/2005CN1639153A Indolylmaleimide derivatives
07/13/2005CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors
07/13/2005CN1639151A Novel azepane derivatives
07/13/2005CN1639150A 异喹啉衍生物 Isoquinoline derivatives
07/13/2005CN1639149A Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
07/13/2005CN1639148A 喹啉衍生物 Quinoline derivatives
07/13/2005CN1639133A Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them
07/13/2005CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/13/2005CN1639125A New inhibitors of histone deacetylase
07/13/2005CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists
07/13/2005CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/13/2005CN1639121A 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
07/13/2005CN1639120A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
07/13/2005CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
07/13/2005CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
07/13/2005CN1638823A N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
07/13/2005CN1638771A Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral
07/13/2005CN1638761A Azetidine derivatives as CCR-3 receptor antagonists
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
07/13/2005CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals
07/13/2005CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636983A Substituted heterocyclic compounds
07/13/2005CN1636981A Uracil compounds and their use
07/13/2005CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
07/13/2005CN1210275C Respiratory syncytial virus replication inhibitors
07/13/2005CN1210274C Piperazine and piperidine derivatives
07/13/2005CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/13/2005CN1210265C Phthalazine derivatives and remedies for erectile dysfunction
07/13/2005CN1210261C Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity